Obesity, Insulin Resistance, and Cancer Prognosis: Implications for Practice for Providing Care among Cancer Survivors

Journal of the American Dietetic Association

Volumn 109, Issue 8, 2009, Pages 1346-1353

  Parekh, Niyati ^a   Okada, Tomoko ^a   Lu Yao, Grace L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CYTOKINE; LEPTIN;

ARTICLE; BLOOD; DIETETICS; DISEASE COURSE; HEALTH BEHAVIOR; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE; METABOLISM; METHODOLOGY; MORTALITY; NEOPLASM; OBESITY; ORGANIZATION AND MANAGEMENT; PREVALENCE; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; UNITED STATES;

ADIPOKINES; ADIPONECTIN; CYTOKINES; DIETETICS; DISEASE PROGRESSION; HEALTH BEHAVIOR; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LEPTIN; LIFE STYLE; NEOPLASMS; OBESITY; PREVALENCE; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 67650995817     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2009.05.001     Document Type: Article

References (57)

1. American Cancer Society. Cancer Facts and Figures 2008 (2008), American Cancer Society, Atlanta, GA. http://www.cancer.org/docroot/stt/content/stt_1x_cancer_facts_and_figures_2008.asp American Cancer Society Web site. http://www.cancer.org/docroot/stt/content/stt_1x_cancer_facts_and_figures_2008.asp. Accessed February 24, 2009.
2. In: Ries L.A.G., Melbert D., Krapcho M., Stinchcomb D.G., Howlader N., Horner M.J., Mariotto A., Miller B.A., Feuer E.J., Altekruse S.F., Lewis D.R., Clegg L., Eisner M.P., Reichman M., and Edwards B.K. (Eds). SEER Cancer Statistics Review, 1975-2005 (2007), National Cancer Institute, Bethesda, MD
3. Edwards B.K., Howe H.L., Ries L.A., Thun M.J., Rosenberg H.M., Yancik R., Wingo P.A., Jemal A., and Feigal E.G. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 94 (2002) 2766-2792
4. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M.J. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
5. US Mortality Data, 1960-2004 (2006), National Center for Health Statistics, Centers for Disease Control and Prevention
6. In: Boyle P.L., and Levin B. (Eds). World Cancer Report 2008, World Health Organization (2008), International Agency for Research on Cancer, Lyon, France
7. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
8. Renehan A.G., Roberts D.L., and Dive C. Obesity and cancer: Pathophysiological and biological mechanisms. Arch Physiol Biochem 114 (2008) 71-83
9. Ioannou G.N., Bryson C.L., and Boyko E.J. Prevalence and trends of insulin resistance, impaired fasting glucose, and diabetes. J Diabetes Complications 21 (2007) 363-370
10. In: Hewitt M., Greenfield S., and Stovall E. (Eds). From Cancer Patient to Cancer Survivor: Lost in Transition (2005), National Academies Press, Washington DC
11. Hausman G.J., and Richardson R.L. Adipose tissue angiogenesis. J Anim Sci 82 (2004) 925-934
12. Lee H.Y., Chun K.H., Liu B., Wiehle S.A., Cristiano R.J., Hong W.K., and Cohen P. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Cancer Res 62 (2002) 3530-3537
13. Noguchi Y., Yoshikawa T., Marat D., Doi C., Makino T., Fukuzawa K., Tsuburaya A., Satoh S., Ito T., and Mitsuse S. Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-alpha expression in skeletal muscle. Biochem Biophys Res Commun 253 (1998) 887-892
14. Riserus U., Arnlov J., and Berglund L. Long-term predictors of insulin resistance: Role of lifestyle and metabolic factors in middle-aged men. Diabetes Care 30 (2007) 2928-2933
15. Goodpaster B.H., Katsiaras A., and Kelley D.E. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 52 (2003) 2191-2197
16. Pittas A.G., Joseph N.A., and Greenberg A.S. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 89 (2004) 447-452
17. Frankenberry K.A., Somasundar P., McFadden D.W., and Vona-Davis L.C. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg 188 (2004) 560-565
18. Sharma D., Saxena N.K., Vertino P.M., and Anania F.A. Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr Relat Cancer 13 (2006) 629-640
19. Fischer S., Hanefeld M., Haffner S.M., Fusch C., Schwanebeck U., Köhler C., Fücker K., and Julius U. Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass. Acta Diabetol 39 (2002) 105-110
20. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 4 (2004) 540-550
21. Choi K.M., Ryu O.H., Lee K.W., Kim H., Seo J.A., Kim S.G., Kim N.H., Choi D.S., and Baik S.H. Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract 75 (2006) 235-240
22. Fain J.N., Madan A.K., Hiler M.L., Cheema P., and Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145 (2004) 2273-2282
23. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115 (2005) 911-919
24. Il'yasova D., Colbert L.H., Harris T.B., Newman A.B., Bauer D.C., Satterfield S., and Kritchevsky S.B. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14 (2005) 2413-2418
25. Barb D., Williams C.J., Neuwirth A.K., and Mantzoros C.S. Adiponectin in relation to malignancies: A review of existing basic research and clinical evidence. Am J Clin Nutr 86 (2007) S858-S866
26. Miyoshi Y., Funahashi T., Kihara S., Taguchi T., Tamaki Y., Matsuzawa Y., and Noguchi S. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9 (2003) 5699-5704
27. Freedland S.J., Sokoll L.J., Platz E.A., Mangold L.A., Bruzek D.J., Mohr P., Yiu S.K., and Partin A.W. Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy. J Urol 174 4 Pt 1 (2005) 1266-1270
28. Goktas S., Yilmaz M.I., Caglar K., Sonmez A., Kilic S., and Bedir S. Prostate cancer and adiponectin. Urology 65 (2005) 1168-1172
29. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 (2003) 1625-1638
30. Rodriguez C., Patel A.V., Calle E.E., Jacobs E.J., Chao A., and Thun M.J. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 10 (2001) 345-353
31. Batty G.D., Shipley M.J., Jarrett R.J., Breeze E., Marmot M.G., and Smith G.D. Obesity and overweight in relation to organ-specific cancer mortality in London (UK): Findings from the original Whitehall study. Int J Obes (Lond) 29 (2005) 1267-1274
32. Siddiqui S.A., Inman B.A., Sengupta S., Slezak J.M., Bergstralh D.J., Leibovich B.C., Zincke H., and Blute M.L. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer 107 (2006) 521-529
33. Freedland S.J., Isaacs W.B., Mangold L.A., Yiu S.K., Grubb K.A., Partin A.W., Epstein J.I., Walsh P.C., and Platz E.A. Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years. Clin Cancer Res 11 (2005) 2883-2888
34. Amling C.L., Riffenburgh R.H., Sun L., Moul J.W., Lance R.S., Kusuda L., Sexton W.J., Soderdahl D.W., Donahue T.F., Foley J.P., Chung A.K., and McLeod D.G. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22 (2004) 439-445
35. Trevisan M., Liu J., Muti P., Misciagna G., Menotti A., and Fucci F. Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 10 (2001) 937-941
36. Colangelo L.A., Gapstur S.M., Gann P.H., Dyer A.R., and Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 11 (2002) 385-391
37. Goodwin P.J., Ennis M., Pritchard K.I., Trudeau M.E., Koo J., Madarnas Y., Hartwick W., Hoffman B., and Hood N. Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study. J Clin Oncol 20 (2002) 42-51
38. Jee S.H., Ohrr H., Sull J.W., Yun J.E., Ji M., and Samet J.M. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293 (2005) 194-202
39. Monajemi H., Stroes E., Hegele R.A., and Fliers E. Inherited lipodystrophies and the metabolic syndrome. Clin Endocrinol (Oxf) 67 (2007) 479-484
40. Misra A., Jaiswal A., Shakti D., Vikram N.K., Pandey R.M., Kondal D., and Bhushan B. Novel phenotypic markers and screening score for the metabolic syndrome in adult Asian Indians. Diabetes Res Clin Pract 79 (2008) E1-E5
41. Griggs J.J., and Sabel M.S. Obesity and cancer treatment: Weighing the evidence. J Clin Oncol 26 (2008) 4060-4062
42. American Cancer Society: Half the cancer deaths could be prevented. CA Cancer J Clin 55 (2005) 209-210
43. Holmes M.D., Chen W.Y., Feskanich D., Kroenke C.H., and Colditz G.A. Physical activity and survival after breast cancer diagnosis. JAMA 293 (2005) 2479-2486
44. Chlebowski R.T., Blackburn G.L., Thomson C.A., Nixon D.W., Shapiro A., Hoy M., Goodman M.T., Giuliano A.E., Karanja N., McAndrew P., Hudis C., Butler J., Merkel D., Kristal A., Caan B., Michaelson R., Vinciguerra V., Del Prete S., Winkler M., Hall R., Simon M., Winters B.L., and Elashoff R.M. Dietary fat reduction and breast cancer outcome: Interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 98 (2006) 1767-1776
45. Doyle C., Kushi L.H., Byers T., Courneya K.S., Demark-Wahnefried W., Grant B., McTiernan A., Rock C.L., Thompson C., Gansler T., Andrews K.S., The 2006 Nutrition, and Physical Activity and Cancer Survivorship Advisory Committee; American Cancer Society. Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide for informed choices. CA Cancer J Clin 56 (2006) 323-353
46. Smith J.C., Bennett S., Evans L.M., Kynaston H.G., Parmar M., Mason M.D., Cockcroft J.F., Scanlon M.F., and Davies J.S. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab 86 (2001) 4261-4267
47. Seagle H.M., Strain G.W., Makris A., and Reeves R.S. Position of the American Dietetic Association: Weight management. J Am Diet Assoc 109 (2009) 330-346
48. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: A global perspective (2007), American Institute for Cancer Research, Washington, DC
49. Wolever T.M., Jenkins D.J., Jenkins A.L., and Josse R.G. The glycemic index: Methodology and clinical implications. Am J Clin Nutr 54 (1991) 846-854
50. Fung T.T., Rimm E.B., Spiegelman D., Fifai N., Tofler G.H., Willett W.C., and Hu F.B. Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 73 (2001) 61-67
51. Rivellese A.A., De Natale C., and Lilli S. Type of dietary fat and insulin resistance. Ann N Y Acad Sci 967 (2002) 329-335
52. Meyerhardt J.A., Heseltine D., Niedzwiecki D., Hollis D., Saltz L.B., Mayer R.J., Thomas J., Nelson H., Whittom R., Hantel A., Schilsky R.L., and Ruchs C.S. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803. J Clin Oncol 24 (2006) 3535-3541
53. Irwin M.L., Smith A.W., McTiernan A., Ballard-Barbash R., Cronin K., Gilliland F.D., Baumgartner R.N., Baumgartner K.B., and Bernstein L. Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: The Health, Eating, Activity, and Lifestyle Study. J Clin Oncol 26 (2008) 3958-3964
54. Ngo T.H., Barnard R.J., Leung P.S., Cohen P., and Aronson W.J. Insulin-like growth factor I (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: Possible mediators for the effects of diet and exercise on cancer cell survival. Endocrinology 144 (2003) 2319-2324
55. Blanchard C.M., Courneya K.S., Stein K., and American Cancer Society's SCS-II. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: Results from the American Cancer Society's SCS-II. J Clin Oncol 26 (2008) 2198-2204
56. American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee, Kushi L.H., Byers T., Doyle C., Bandera E.V., McCullough M., McTiernan A., Gansler T., Andrews K.S., and Thun M.J. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. [erratum appears in: CA Cancer J Clin. 2007;57:66]. CA Cancer J Clin 56 (2006) 254-281 quiz 313-314
57. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective (2007), American Institute for Cancer Research, Washington, DC